APYX MEDICAL CORPORATION's ticker is APYX and the CUSIP is 03837C106. A total of 63 filers reported holding APYX MEDICAL CORPORATION in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,018 | +212.4% | 15,943 | +391.0% | 0.00% | +100.0% |
| Q2 2023 | $16,332 | -49.0% | 3,247 | -54.6% | 0.00% | 0.0% |
| Q3 2022 | $32,000 | +3100.0% | 7,147 | +3565.1% | 0.00% | – |
| Q2 2022 | $1,000 | -97.4% | 195 | -96.7% | 0.00% | – |
| Q1 2022 | $39,000 | +200.0% | 5,988 | +471.4% | 0.00% | – |
| Q4 2021 | $13,000 | -40.9% | 1,048 | -34.0% | 0.00% | -100.0% |
| Q3 2021 | $22,000 | -47.6% | 1,587 | -61.2% | 0.00% | 0.0% |
| Q2 2021 | $42,000 | +121.1% | 4,093 | +112.3% | 0.00% | – |
| Q1 2021 | $19,000 | -82.7% | 1,928 | -87.4% | 0.00% | -100.0% |
| Q4 2020 | $110,000 | -39.9% | 15,328 | -60.6% | 0.00% | +50.0% |
| Q3 2020 | $183,000 | +335.7% | 38,865 | +415.5% | 0.00% | 0.0% |
| Q2 2020 | $42,000 | +425.0% | 7,540 | +242.1% | 0.00% | – |
| Q1 2020 | $8,000 | -38.5% | 2,204 | +18.2% | 0.00% | -100.0% |
| Q3 2019 | $13,000 | +550.0% | 1,864 | +592.9% | 0.00% | – |
| Q2 2019 | $2,000 | – | 269 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Archon Capital Management LLC | 3,452,030 | $11,046,496 | 2.90% |
| AIGH Capital Management LLC | 1,895,231 | $6,064,739 | 2.87% |
| Taylor Frigon Capital Management LLC | 621,147 | $1,987,670 | 1.10% |
| Worth Venture Partners, LLC | 462,606 | $1,480,339 | 0.88% |
| PERKINS CAPITAL MANAGEMENT INC | 211,800 | $678 | 0.67% |
| PURA VIDA INVESTMENTS, LLC | 836,990 | $2,678,368 | 0.51% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 372,106 | $1,190,739 | 0.19% |
| GREENWOOD CAPITAL ASSOCIATES LLC | 301,809 | $965,789 | 0.14% |
| RTW INVESTMENTS, LP | 1,777,194 | $5,687,021 | 0.12% |
| Legato Capital Management LLC | 140,062 | $448,198 | 0.06% |